There were 1,857 press releases posted in the last 24 hours and 311,731 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Gannex Announces First Subject Dosed in the U.S. Drug-Drug Interaction Study of FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image